18
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T5513 | RO-3 | P2X Receptor | |
RO3 is a selective antagonist of homomeric P2X3 and heteromeric P2X2/3 receptor | |||
T30611 | Bufuralol | Ro3-4787,Ro 3-4787,Ro-3-4787 | |
Bufuralol is a Adrenergic Agent. | |||
TP2206 | [Leu31,Pro34]-Neuropeptide Y (porcine) | Neuropeptide Y Receptor | |
High affinity neuropeptide Y Y1 receptor agonist | |||
TP2020L | [Pro3]-GIP (Mouse) acetate | Others | |
[Pro3]-GIP (Mouse) acetate is mouse [Pro3]-GIP. [Pro3]-GIP is a GIP receptor antagonist. | |||
T69360 | RO3244794 | Prostaglandin Receptor | |
RO3244794 is a selective prostacyclin (IP) receptor antagonist that can be used to study liver injury. | |||
T2634 | Ro3280 | RO 3280,Ro5203280 | PLK |
Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM). | |||
T71420 | RO314724 | ||
RO314724 is a HDAC inhibitor. RO314724 is also a a reversible, tightly binding, MMP inhibitor with a Ki of 26 nm. Matrix metalloproteinases (MMPs) belong to the key enzymes of the proteolytic destruction of cartilage m... | |||
T76313 | (Pro3) GIP, human | ||
(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is a stable and specific full agonist for the human GIP receptor (hGIPR) with a high binding affinity, represented by K i / K d values of 0.90 nM. It shows eff... | |||
T76442 | (Leu31,Pro34)-Peptide YY (human) | ||
(Leu31,Pro34)-Peptide YY (human) is a derivative of Peptide YY, acting as a potent and selective Y1 receptor agonist with a dissociation constant (KD) of 1.0 nM [1]. | |||
T34903 | TO-PRO3 iodide | TOPRO3 iodide,TO-PRO3 iodide salt | |
TO-PRO3 iodide is a nucleic acid stain that can stain the nucleus of cells in different states, including living, early apoptotic, and necrotic cells. | |||
T83499 | [D-Phe2,6, Pro3]-LH-RH | ||
[D-Phe2,6, Pro3]-LH-RH is a potent antagonist of luteinizing hormone-releasing hormone (LHRH). | |||
TP1985 | [Leu31,Pro34]-Neuropeptide Y(human,rat) | [Leu31,Pro34]-Neuropeptide Y (human, rat) | |
High affinity neuropeptide Y Y1 receptor agonist (Ki = 0.39 nM). Also shows affinity for Y4 and Y5 receptors. | |||
TP2021 | [Pro3]-GIP (Rat) | ||
High affinity rat GIP receptor partial agonist (Kd = 13 nM). Increases cAMP accumulation in COS-7 cells transfected with rat GIP receptor, while also acting as a competitive antagonist of GIP. | |||
T75912 | [Leu31,Pro34]-Neuropeptide Y(human,rat) TFA | ||
[Leu31,Pro34]-Neuropeptide Y(human,rat) TFA acts as a specific agonist for the neuropeptide Y Y1 receptor, while also activating receptors Y4 and Y5. This compound is known to elevate blood pressure in anesthetized rats ... | |||
T76441 | (Pro34)-Peptide YY (human) | ||
(Pro34)-Peptide YY (human) is a highly Y 1 -selective full agonist of Peptide YY /neuropeptide Y receptors [1] . | |||
TP2020 | [Pro3]-GIP (Mouse) | ||
GIP receptor antagonist (IC50 = 2.6μM). Inhibits GIP-stimulated insulin release from pancreatic β cells in vitro. In ob/ob mice, blocks the effects of GIP on insulin release and plasma glucose levels. Also improves intra... | |||
T80087 | (Leu31,Pro34)-Peptide YY (human) (TFA) | Neuropeptide Y Receptor | |
"(Leu31,Pro34)-Peptide YY (human) (TFA) is the trifluoroacetic acid (TFA) form of (Leu31,Pro34)-Peptide YY (human), a derivative of Peptide YY that acts as a potent and selective Y1 agonist, exhibiting a dissociation con... | |||
T34370 | RO320-2947/001 | RO-320-2947/001,RO 320-2947/001 | |
RO320-2947/001 is a bioactive chemical. |